EVEREST GROUP, LTD. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EVEREST GROUP, LTD. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $17.50B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $17.28B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $14.59B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $12.06B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $11.87B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $9.60B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $8.23B | Feb 28, 2022 |
| FY2019 | Jun 30, 2019 | $2.01B | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $1.97B | Mar 2, 2020 |
| FY2020 | Dec 31, 2018 | $7.36B | Mar 1, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.59B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.37B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.52B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $597.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.38B | Feb 28, 2024 |
| FY2015 | Dec 31, 2015 | $357.28M | Feb 29, 2016 |
| FY2015 | Sep 30, 2015 | $88.55M | Feb 29, 2016 |
| FY2015 | Jun 30, 2015 | $209.06M | Feb 29, 2016 |
| FY2015 | Mar 31, 2015 | $322.98M | Feb 29, 2016 |
| FY2015 | Dec 31, 2014 | $340.12M | Feb 29, 2016 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.07B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.96B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $4.55B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.70B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $3.83B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.87B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $1.85B | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $610.07M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $1.16B | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $1.38B | Mar 1, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $62.51B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $56.34B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $49.40B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $39.97B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $38.19B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $32.71B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $27.32B | Mar 1, 2021 |
| FY2019 | Jun 30, 2019 | $26.34B | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $25.59B | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | $24.75B | Mar 2, 2020 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $47.05B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $42.47B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $36.20B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $31.53B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $28.05B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $22.99B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $18.19B | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | $16.89B | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | $15.22B | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $13.25B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.46B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $13.88B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $13.20B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $8.44B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $10.14B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $9.73B | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $9.13B | Feb 28, 2022 |
| FY2019 | Jun 30, 2019 | $8.84B | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $8.39B | Mar 2, 2020 |
| FY2020 | Dec 31, 2018 | $7.86B | Mar 1, 2021 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $16.57B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $15.31B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $14.27B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $12.04B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $11.70B | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | $10.57B | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | $10.31B | Mar 1, 2021 |
| FY2019 | Jun 30, 2019 | $10.10B | Mar 2, 2020 |
| FY2019 | Mar 31, 2019 | $9.83B | Mar 2, 2020 |
| FY2019 | Dec 31, 2018 | $9.53B | Mar 2, 2020 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $656.10M | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $635.07M | Mar 1, 2019 |
| FY2018 | Dec 31, 2016 | $481.92M | Mar 1, 2019 |
| FY2018 | Dec 31, 2015 | $283.66M | Mar 1, 2019 |
| FY2017 | Dec 31, 2014 | $437.47M | Mar 1, 2018 |
| FY2016 | Dec 31, 2013 | $611.38M | Mar 1, 2017 |
| FY2015 | Dec 31, 2012 | $537.05M | Feb 29, 2016 |
| FY2014 | Dec 31, 2011 | $448.65M | Mar 2, 2015 |
| FY2013 | Dec 31, 2010 | $258.41M | Mar 3, 2014 |
| FY2012 | Dec 31, 2009 | $247.60M | Mar 1, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 31 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 60 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 15 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 34 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 6 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 4 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 5 | Mar 1, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 37 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 31 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 60 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 15 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 34 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Mar 1, 2021 |
| FY2020 | Sep 30, 2020 | 6 | Mar 1, 2021 |
| FY2020 | Jun 30, 2020 | 4 | Mar 1, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Mar 1, 2021 |
| FY2020 | Dec 31, 2019 | 5 | Mar 1, 2021 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 74.40M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 74.30M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | 74.20M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 69.90M | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | 69.80M | Feb 24, 2023 |
| FY2021 | Dec 31, 2020 | 69.62M | Feb 28, 2022 |
| FY2020 | Dec 31, 2019 | 69.46M | Mar 1, 2021 |
| FY2019 | Dec 31, 2018 | 69.20M | Mar 2, 2020 |
| FY2018 | Dec 31, 2017 | 69.04M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 68.87M | Mar 1, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $335.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $334.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $288.00M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $255.00M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $247.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $249.00M | Feb 24, 2023 |
| FY2021 | Dec 31, 2019 | $234.32M | Feb 28, 2022 |
| FY2020 | Dec 31, 2018 | $216.22M | Mar 1, 2021 |
| FY2019 | Dec 31, 2017 | $207.24M | Mar 2, 2020 |
| FY2018 | Dec 31, 2016 | $195.38M | Mar 1, 2019 |